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T

he field of health law is driven in part by new medical technologies
and scientific discoveries such as innovative diagnostic tests and
treatments. Some of the most significant advancements in medicine
over the last two decades have been in the field of genetics. As the field has
developed, we have had the opportunity as health law teachers and scholars
to look at ways that advances in genetics have affected or may affect the legal
system and suggest ways that the law should change to accommodate this
relatively new field of technology.
Advances in genetics have been fueled by the Human Genome Project.
Started in 1990, the Human Genome Project was a 13-year effort coordinated
by the U.S. Department of Energy and the National Institutes of Health to
identify all of the approximately 20,000-25,000 genes in human DNA and
determine the sequences of the 3 billion chemical base pairs that make up
human DNA. Originally, researchers predicted that mapping the human
genome would take 15 years but rapid technological advances allowed
scientists to complete the mapping in 2003. The Project was primarily designed to improve our understanding of health and genetic disease and to
improve the quality of life for individuals who would otherwise be debilitated by disease. Based on information gathered by the Human Genome
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n this issue of the Law & Health Care Newsletter we focus on how
our faculty, students, and graduates have contributed to the legal and
policy debates raised by new advances in genetics through their scholarship, legislative advocacy and work with government agencies. We report
on recent faculty scholarship on the use of health-related genetic tests in
court proceedings and on the unique collaboration between our faculty
and graduates now working at the National Human Genome Research
Institute. Finally, we proudly share the accomplishments of a number of
our health law certificate recipients as they begin their careers in health
law.
Diane E. Hoffmann, JD, MS
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Project, genetic tests have been
developed to assist in diagnosis,
treatment, and prevention of physical
disease. These tests can identify
diseases and conditions before they
appear and have the potential to
indicate, among other things, individual susceptibilities to certain
behaviors and addictions. If we think
of DNA tests for identification purposes (in criminal trials and paternity
suits) as the “first generation” of
genetic tests, these health-related,
post-Human Genome Project tests can
be thought of as the “second generation” of genetic tests and, just as first
generation tests had a revolutionary
effect on the legal world in terms of
criminal and paternity proceedings,
second generation tests promise to
leave their mark on the legal world.
Almost 20 years ago, in 1988, the
first reported appellate discussion of
the admissibility of DNA testing to
prove identity took place.1 Since
that time, courts have enthusiastically embraced DNA tests for the
purpose of identifying, or excluding
from consideration, the perpetrator
of a crime or the father of a child.2
Although there were early controversies and challenges regarding the
validity of these tests, over the past
two decades they have become
routine and are overwhelmingly
accepted by courts.3 There are over
200 published court opinions
supporting the admissibility of DNA
tests in the courtroom.4 This
widespread acceptance went handin-hand with the development of
DNA testing standards and the
blossoming of DNA laboratories
across the county.5
While the Human Genome
Project was designed for therapeutic
purposes, some lawyers have seized
upon a distinctly non-therapeutic use
for genetic tests – to introduce
evidence of disease susceptibility and
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behavioral conditions to support
various propositions in court proceedings. Courts are already being
faced with requests to admit various
types of genetic tests in different
contexts and, looking forward, it is
easy to imagine numerous other legal
situations in which the use of genetic
information might be attractive to
litigants. How genetic information is
used in the courts may determine,
among other things, whether individuals 1) are compensated for their
medical costs and pain and suffering
(in malpractice, product liability, or
toxic tort litigation); 2) will be hired
to perform a job; 3) will adopt a child
or obtain child custody after divorce
or separation; or 4) will be held
criminally responsible.6
For the last four years, we have
studied the use of second generation
genetic tests in the courtroom. We
began our research by undertaking an
empirical study of state and federal
trial court judges in Maryland to better
understand how judges make (or
would make) decisions about whether
to compel or admit genetic tests. The
study focused on how health-related
genetic information actually comes
before the trier of fact. Inclusion of
genetic test results in a trial depends
both on judges’ attitudes toward such
tests and what is scientifically admissible at trial. To better understand
judicial attitudes, we designed our
survey around a series of hypothetical
criminal and civil cases. In a number
of those cases, judges had significant
differences of opinion on whether a
genetic test should be admitted or
compelled. For example, in a criminal case, 54% of the state and 38% of
the federal judges said they would
admit a positive genetic test for
schizophrenia to show that the
defendant did not have the necessary
intent to commit the crime. The
judges were more reluctant to order a
similar test in the sentencing phase of
a trial. Only 18% of the state and 15%
of the federal judges said they would

compel a defendant to be tested for a
presence and severity of specific
Maryland judiciary has also recently
condition that brings on bouts of rage
disease states) to help determine the
established a program to educate a
in order to show the defendant’s
impact of a toxic exposure on an
group of judges about scientific and
potential for violence. In meetings
individuals’ development of a disease
medical issues so that they may be
with groups of judges about these
more informed in adjudicating cases
or to introduce evidence showing
results, they commented that, even
chromosomal damage due to chemical
though there are fewer
exposure. Courts have
privacy concerns and
inconsistently to
In general, we found that the judges, in their responded
constitutional matters at
requests to admit these tests.13
the sentencing stage of decisions about whether or not to admit or
In addition to their use in
a trial, they were
proving or disproving
compel the tests, evidenced a sophisticated
reluctant to order a test
causation, it is conceivable
that might brand or
understanding of the complex issues at stake. that genetic test results
7
stigmatize a defendant.
could play a role in the
In general, we
damages portion of a civil
found that the judges, in their
case, especially in the area of probased on scientific or medical evidecisions about whether or not to
jected mortality. Information
dence.8
The results of our survey were first
admit or compel the tests, evidenced
regarding a plaintiff’s genetic profile,
published in October 2005 in an issue
specifically information regarding
a sophisticated understanding of the
of the journal Science. Our empirical
complex issues at stake. In part, we
conditions that might shorten a
research led us to write a longer piece
plaintiff’s lifespan, could influence a
were surprised by the results as they
on the implications of our findings for
did not reflect the widespread
final damages award.
the legal system. That article will be
Although relatively few judicial
acceptance that DNA tests for identipublished this fall in a forthcoming
fication have received in the courtopinions exist in which the admisissue of the Maryland Law Review.9 In
room in the context of criminal and
sion of genetic tests has been in
paternity cases. Our findings also led
question, in a review of judicial
the article, entitled “Judging Genes:
us to question whether our results
Implications of the Second Generation
settlements and verdicts between
1995 and 2005, we uncovered 127
were representative of Maryland trial
of Genetic Tests in the Courtroom,”
court judges as well as whether we
cases in which genetic information
we point out that the introduction of
was a factor.14 Of those 127 cases,
would find similar results in other
these second generation genetic tests
jurisdictions. Our response rate was
in litigation has been relatively slow.10
55% were in the context of medical
quite good – 72% of circuit court
malpractice, 16% involved child lead
There have been few judicial opinjudges and 64% of federal district
ions regarding the admission or
poisoning, 21% involved negligence
court judges completed our survey.
compelling of genetic tests for the
and, 8% were miscellaneous cases.
We attribute this in large part to the
purposes of providing health informaOverall, we were able to determine
assistance and support of Chief Judge
that genetic tests were actually
tion about one of the parties. The
Robert Bell of the Maryland Court
majority of these cases are in the torts
performed in slightly over one
of Appeals and the close relationship
area, specifically medical malpractice
quarter of the cases (27.6%).
between the law school and the
In terms of criminal cases, although
cases involving birth injury. This has
Maryland judiciary. While the
most typically occurred in cases where
the use of genetic tests to establish
response rate leads us to believe our
identity is commonplace, there are
a physician introduces evidence of a
results may be representative of the
genetic disorder to rebut a claim that
almost no reported cases where
Maryland judiciary, it is not clear
the physician acted negligently during
health- or behavior-related genetic
11
whether they are representative of
tests have been used. Nonetheless
labor and/or delivery. Genetic tests
the responses we would receive in
have also been used in a small numseveral commentators have hypothber of reported toxic torts/product
esized the use of such tests in a variety
other jurisdictions. A number of
liability cases – most often by defenof contexts, including 1) proving or
members of the Maryland judiciary
disproving mens rea by introducing
and Maryland federal district court
dants to argue that the plaintiff’s
injuries are genetically based and not
evidence that indicates whether a
judges have had a significant interest
defendant has or does not have a
the result of exposure to a harmful
in the use of genetic tests in the
12
substance or product. In a few toxic
particular condition or behavioral
courtroom and have attended a
tort cases, parties have sought to use
trait and 2) predicting “future
number of judicial education
biomarkers (tests that indicate the
programs devoted to this topic. The
Cont. on page 18
www.law.umaryland.edu/specialty/maryhealth/index.asp – Law & Health Care Newsletter 3

THE LAW & HEALTH CARE PROGRAM AND THE NATIONAL HUMAN
GENOME RESEARCH INSTITUTE: A UNIQUE RELATIONSHIP

T

he work of several faculty
members at the University of
Maryland School of Law on
genetics issues has led to a unique
affiliation between the Law & Health
Care Program and the National
Human Genome Research Institute
(NHGRI) in Bethesda, Maryland.
NHGRI is one of the 27 institutes
and centers that make up the National
Institutes of Health (NIH). It was
established in 1989 to represent NIH
in the international Human Genome
Project. The NHGRI is part of the
international effort to study the human
genome and, in addition, sponsors
research exploring the potential
ethical, legal, and social consequences
of the genetics revolution in medicine.
NHGRI Director Francis Collins, a
noted physician-geneticist, is known
for his commitment to tackling the
difficult ethical questions that surround genetic research and testing.
In addition to Dean Karen
Rothenberg’s work with the genetics
community at NIH, Professors
Deborah Hellman and Lawrence
Sung have had close professional ties
with the Institute. Sung has been a
consultant to NHGRI on matters
relating to public access to genomic
database information, and Hellman
served for four years on the Ethical,
Legal, and Social Implications Peer
Review Committee which reviewed
proposals for NHGRI funding.
Law & Health Care Program
students have benefited greatly over
the years from these faculty relationships with NHGRI and from
NHGRI’s proximity to the law
school campus. Barbara Fuller, who
graduated from the law school in
1996, has been at NHGRI since 1998.
She began as a Senior Policy Analyst
and is now Assistant Director for
Ethics. In her current position, she
4

MD/law student with an interest in
the intersection of science and ethics,
developed an exhaustive catalog of all
state laws regarding genetic discrimination during his time at NHGRI.
Another law school alum, M.
Katherine (MK) Holohan ’03, has
been a Senior Health Policy Analyst at
NHGRI since 2005. Her main duties
are legislative in nature, working
closely with Congressional staff,
preparing Congressional testimony on
Barbara Fuller and Francis Collins,
behalf of NHGRI witnesses, and
Director of NHGRI
attending hearings and markups of
manages the Institute’s professional
health-related legislation. She has
ethics program, which includes such
been extensively involved with the
issues as financial disclosure, conflicts
development of H.R. 493, the
of interest, standards of conduct,
Genetic Information Nondiscriminapolitical activity, and procurement
tion Act of 2007 (which passed the
integrity requirements. Fuller is past
House on April 25). She works
Chair of the Foundation for Research
closely with Director Collins, briefand Education and past President of
ing him on legislative activities and
the American Health Information
developing policies related to
Management Association. While
genomic medicine, intellectual
Fuller was at the law school,
property, and privacy
she worked closely with
protections of genetic
then Professor, now Dean,
information, among
Karen Rothenberg on
other things. Prior to
scholarship relating to
joining NHGRI, MK
genetic research. They coworked for Wickwire
authored an article entitled
Gavin P.C., a private
“Privacy in Genetics Relaw firm in Vienna,
search” which appeared in
Virginia on regulathe August 1999 issue of
tory, rulemaking, and
Science. In fact, Fuller
government
attributes her successful
contracing issues.
transition from law school
MK believes that
MK Holohan
to NHGRI to her research
law students should
with Dean Rothenberg.
take advantage of the
Barbara has remained close to the
law school’s externship program,
Law & Health Care Program over the
which she credits with developing her
years – speaking to Health Law
interest in legislative issues and
Practice Workshop students and
helping her secure her current
supervising student externs. While
position. In her second year in law
Branch Chief of the Policy and
school, she externed for the House
Program Analysis Branch, she
Committee on Government Reform,
supervised Steve Hudson, a 2001
Subcommittee on the District of
graduate of the law school. Steve, an
Columbia. She was working for the
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HEALTH LAW & BIOTECHNOLOGY –
WORKING AT THE INTERSECTION OF HEALTH
LAW AND INTELLECTUAL PROPERTY
Committee when the terrorist attacks
occurred on September 11, and had
the unique opportunity to help
organize a critical emergency preparedness hearing that the Committee scrambled to put together after
the attacks. Her advice to students is
to do as many externships and to
make as many contacts as possible
during law school. The connections
she made during law school have
led to several job offers since
graduation – the best being her
current position at NHGRI.
Christine Norris, a third year
student at the law school, worked
with MK last year as a Legislative
Research Assistant. She had the
opportunity to research issues
relating to genetics in state, federal,
and international law and to comment on pending legislation relating
to genetic employment and insurance discrimination, human subject
research, stem cell research, and
genomics and personalized medicine. Her externship led to an
independent research paper on
genetic discrimination that will be
published in the forthcoming
edition of the University of Maryland
Law Journal of Race, Religion, Gender
and Class.
On her time at NHGRI,
Christine commented, “the
experience was fantastic because it
allowed me to apply my scientific
background in proteomics and
genomics to the law. It was a dream
to help make an impact on the
cutting edge issues that NHGRI
works on. I believe the work of the
Institute will help bring the science
of genomics to health care practice
and everyday people and, at the
same time, protect citizens from
serious problems that could arise
from the genomic era.”

S

tudents like Joanne Hawana
(see story page 14) come to
the University of Maryland
School of Law looking to combine a
focus on health law and intellectual
property law. These students often
have advanced degrees in science or
engineering. The School of Law’s
strong programs in health law and
intellectual property law allow them
to pursue their interest at the intersection of both fields through the
school’s Intellectual Property Law
Program (IP Program) and the Law
& Health Care Program. Intellectual property law and health law
intersect most notably in the field of
biotechnology – in areas such as
genetics, pharmaceuticals, medical
technologies, personalized medicine, and toxicogenomics – and it is
in this area that the school’s IP
Program provides unique opportunities for health law students.
These opportunities are enhanced
by the prominence of the State of
Maryland in the area of biotechnology
development. Maryland tops the
nation in research and development
technology spending. Entrepreneur
Magazine recently ranked TEDCO
(Maryland’s state-created technology
transfer and development corporation)
first in the nation for the largest
number of investments in start-up/
seed or early-stage companies for the
fourth consecutive year. Specific to
health-related biotechnology, in
addition to state initiatives, Maryland
is home to a number of federal
research laboratories and agencies
including the National Institutes of
Health (NIH), Food and Drug
Administration (FDA), and the U.S.
Army Research Laboratories.

Maryland is also home to the Human
Genome Project research sponsors
(NIH and the U.S. Department of
Energy) as well as to major research
projects relating to the genome – the
National Human Genome Research
Project, the Institute for Genomic
Research, and Celera Genomics. In
addition, the state boasts three
universities with renowned health
sciences programs - University of
Maryland, the Johns Hopkins
University, and the Uniformed
Services University of Health Sciences.
A unique feature of Maryland’s IP
Program is the Program’s legal
resource center, which is designed
to place students directly into the
center of Maryland’s biotechnology
wave. The Maryland Intellectual
Property Legal Resource Center
(MIPLRC) was established in
February 2002 to provide low-cost
intellectual property services and
other legal assistance to start-up
technology companies and to
explore emerging ethical, legal, and
policy issues in the field of hightechnology and intellectual property. The Center is a collaborative
project of the law school and the
Montgomery County Department of
Economic Development (DED),
which is located in the technologyrich business corridor of Montgomery County. The MIPLRC provides legal services through several
“incubators” located at DED’s
headquarters in the Maryland
Technology Development Center in
Rockville, Maryland and the
University of Maryland, Baltimore
BioPark. Students can work at the
incubators for academic credit as
clinic students.
Cont. on page 6
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Health Law & Biotechnology
Cont. from p. 5

specializing in biotechnology patent
litigation with several national law
The Director of the IP Program,
firms, including as a partner at Nixon
faculty member Lawrence Sung,
Peabody LLP. Sung also served as a
brings years of experience in the area consultant to the National Human
of intellectual property
Genome Research
law to his position.
Institute under the
Sung received his PhD
direction of Francis
in Microbiology from
Collins, Director of
the U.S. Department of
the Institute.
Defense, Uniformed
Sung’s recent
Services University. He
scholarship includes a
has published extenproposal for the
sively in the area of
enactment of a statuintellectual property law
tory elective basic
on issues including
research right to use
biotechnology and
patented technology.
technology transfer. He
The proposal would
Lawrence Sung
is the author of PATENT
amend the patent laws
INFRINGEMENT REMEDIES (BNA Books to exempt from liability the use by an
2004 & Supplements 2005-2006) and academic or non-profit research
annual volumes of THE PATENT LAW
institution of any patented technology,
HANDBOOK (Thomson/West 2003where the entity serves notice on the
2006). Prior to joining the law school, patent holder of a research plan that
Sung was a registered patent attorney
details who will be involved in the

research that incorporates the patented
technology and how the patented
technology will be used. In return, the
entity would have the ability to use
the patented technology royalty-free
for activities within that research plan.
The “research use exemption” is
designed to alleviate concerns among
researchers about the chilling effect on
their work that patents pose and
encourage a freer dissemination of
ideas and more collaborative research
efforts.
Sung also teaches the Biotechnology
and the Law Seminar, which explores
the legal and ethical issues surrounding biotechnology research and
development. In the seminar, Sung
discusses ownership and use issues
relating to genetic data (including
genomics, bioinformatics, and genetic
data privacy) and genetic manipulation
(gene-based research tools, pharmaceutical and agricultural products, and
medical therapies).

TRANSLATING SCHOLARSHIP INTO POLICY: AN INTERVIEW WITH
DEAN KAREN ROTHENBERG ON HER RESEARCH INTO THE
SOCIAL, ETHICAL AND LEGAL IMPLICATIONS OF GENETIC RESEARCH

D

ean and health law scholar Karen
Rothenberg has been writing about
the legal and ethical implications of genetic
research for over fifteen years, and is still
actively involved in raising awareness of
the potential dangers genetic research can
have on individuals and populations. In
this article, Virginia Rowthorn, Managing
Director of the L&HCP, and a former
student of Rothenberg, interviews
Rothenberg about her extensive scholarship
in this area.
When did you first become interested in
genetic research?
In 1991, when I was an Associate
Professor here at the law school, I spent
a sabbatical visiting at the NIH Institute
6

for Child Health & Human Development. At that time, certain genetic tests
were becoming the standard of care for
pregnant women and I became very
interested in the legal and ethical issues
surrounding reproductive genetic
testing. From the beginning, I always
felt that genetic tests carry with them
ethical implications that are different
and potentially more serious than other
medical tests. While I was at NIH, I
co-authored an NIH workshop
statement on the impact of reproductive genetic testing on women. In that
piece, we argued that every woman
should have an opportunity to have
access to genetic services in a way that
will improve her control over her
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reproductive life but such testing must
be conducted within a framework that
is sensitive to her needs and values and
minimizes the potential for coercion.
What led you to move beyond research
that was focused primarily on gender
issues to issues relating to religion and
ethnicity?
I was actually back at NIH as
Special Assistant to the Director of
the Office of Research on Women’s
Health from 1995 to 1996 just after
scientists discovered the BRCA gene
mutations that increase the risk of
breast and ovarian cancer in women
of Ashkenazi Jewish descent. It
concerned me that commercial tests

to detect the mutation were coming
on the market, and that makers of the
tests were targeting Jewish women
even before research on the precise
cancer risk had been completed and
before the social consequences of
wide-scale testing could be evaluated.
Thinking about the explosive effect
BRCA testing was having on Jewish
women pushed me to consider the
unique way that genetic testing can
affect ethnic and racial populations as
well as individuals.
What kind of empirical research have
you done in this area?
After focusing on the BRCA test, I
became interested in the implications
of all types of genetic research for the
Jewish community. In the late 1990s,
several colleagues and I conducted a
multi-year study on attitudes of the
Jewish population to the use of stored
DNA for genetics research. We found
that most of the respondents thought
that researchers and doctors should get
written informed consent before
research samples are taken from an
individual. But more interesting was
our finding that respondents
understood that genetic tests fall on a
continuum in terms of their potential
for creating stigma. Individuals were
much less willing to participate in
research that examined stereotypical
and potentially stigmatizing behavioral
traits as opposed to research that
examined medical illnesses.
How did you become interested in the
implications of genetic research on
religious and ethnic minorities beyond
the Jewish community?
Because of my interest in this area,
I was asked to help plan a Fred
Friendly PBS Seminar Series called
Our Genes/Our Choices. I participated
in one of the programs - Genes on
Trial – which was designed to look at
the intersection of genetics, behavior,
and the law. Along with 15 other
participants, we played assigned roles
in various scenarios designed to tease

out issues for discussion. In one of
the scenarios, we adopted roles
relating to a hypothetical ethnic
group - Tracy Islanders – who have a
higher incidence of alcoholism as
well as a higher incidence of the gene
variant that makes it more likely that
someone will become an alcoholic.
A lot of issues were raised by the
program but one in particular pushed
me in the direction of my current
research. As part of the Tracy Island
scenario, a young man gets drunk,
engages in a bar fight, and kills an
off-duty policeman. The young
Tracy Islander’s lawyer wants to use
his genetic predisposition toward
alcoholism as a defense. Use of
behavior-related tests in the
courtroom raises difficult issues
relating to group stigma.
How can individual genetic tests, which
are usually anonymous or confidential,
result in group stigma?
Individual genetic test results may
be anonymous but they are not
anonymous with respect to the
ethnicity of the participants. My
concern has been this lack of group
anonymity and the fact that genetic
research often reveals susceptibilities
and traits within religious or ethnic
groups. These traits, depending on
what they are, could lead to stigmatization and discrimination. This is
easy to imagine in the case of genetics
research into a person's intelligence
or propensity for violence. Because
these group traits are discovered by
scientists outside the individual
patient context where informed
consent may be obtained, there has
been no clear mechanism to discuss
group risks and no clear process to
give consent on the part of an entire
group. That troubles me.
Does genetic research into group traits
have the potential to disproportionately
affect ethnic and religious minorities?
Yes. After the PBS special, I coauthored an article with a colleague,

Alice Wang, called “The Scarlet
Gene: Behavioral Genetics, Criminal
Law, and Racial and Ethnic Stigma,”1
which explores this phenomenon.
First, genetics research tends to focus
on discrete and insular populations
that share a common ancestry and
that often overlap with socially
constructed racial or ethnic minority
groups. Second, the study of genetic
differences between racial or ethnic
groups appeals to the persistent
impulse in our society to explain
racial and ethnic differences in
biological terms. Finally, because
racial and ethnic minority groups are
disproportionately represented in the
criminal justice system, any effort to
analyze the DNA of criminals will
inevitably be skewed toward these
groups. Going back to what I was
saying about genetic tests falling
along a continuum of potential for
misuse, I think genetic tests for
behavioral traits such as criminality
have a great potential for stigma
because these traits involve a strong
element of individual choice. They
are more closely associated with fault,
even if they are deemed genetic.
This racial or ethnic stigma is even
more powerful when the behavior
associated with the gene coincides
with preexisting stereotypes about a
racial or ethnic group.
What are you studying now?
My colleague Diane Hoffmann and
I have been working on a project on
the introduction of health- and
behavior-related genetic tests in the
courtroom (see article, page 1). That
project has stimulated me to think
about what will happen when these
types of genetic tests are used with
increasing frequency in the courtroom. As discussed in the “Scarlet
Gene” article, as one moves toward
the behavioral end of the spectrum,
the genetic influence on a trait
becomes more uncertain and difficult
to isolate, while the stigma associated
Cont. on page 8
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Interview with Dean Rothenberg
Cont. from p. 7

with such influence becomes more
significant. Widespread use of these
tests in court proceedings could
have a negative impact on the
perception of ethnic and religious
minorities.
Given that new genetic tests, including
tests that uncover behavioral traits, are
continuing to be developed, how can we
limit the harm they may do to religious and ethnic minorities?
I’ve long believed that genetics
research should only be conducted
after a thorough review of the
implications of the research on
individuals, the family, the

community and society. There must
be a strong scientific justification to
support research focusing on a
religious or ethnic minority group.
Research into discrete populations
should be undertaken only because
it’s scientifically necessary, and, in
some cases, maybe not at all.
Where do you see your research
moving in the future?
The ethical and legal questions
surrounding genetic testing are far
from solved. I’ve been struggling
with these issues for 15 years and, in
fact, in the most recent issue of the

Journal of Law, Medicine & Ethics, other
legal and bioethics scholars are
struggling with these issues too. We
all have more work to do in this area.
Diane Hoffmann and I have organized a roundtable at the law school
to begin a discussion among scientists, judges and other academics
about the implications of our work
on the future use of behavior-related
tests in the courtroom for law and
public policy.
Note
1
LAW AND CONTEMPORARY
ISSUES, Vol. 69, Nos. 1 and 2,
Winter/Spring 2006.

R OTHENBERG TESTIFIES ON GENETIC NONDISCRIMINATION ACT OF 2007

E

arlier this year, Karen
Rothenberg, Dean and
Marjorie Cook Professor of
Law at the University of Maryland
School of Law, testified before the
U.S. House of Representatives’
Subcommittee on Health, Employment, Labor, and Pensions as it
considered H.R. 493, the Genetic
Information Nondiscrimination Act of
2007 (which passed the House on
April 25). The bill, which is awaiting
Senate approval, is the latest in a series
of bills appearing before Congress that
are designed to protect individuals
from discrimination in health insurance and employment on the basis of
genetic information. Her most recent
committee testimony came more than
ten years after she first testified before
Congress on the same issue. Then, as
now, Rothenberg expressed her view
that the federal government, as a
matter of public policy, must provide
a comprehensive approach to protection of genetic information.
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Rothenberg has been involved in
writing and promoting legislative
approaches to genetic privacy since the
early 1990s. Her earliest work in the
field involved research regarding state

Dean Karen Rothenberg
legislative approaches to genetic
privacy. This work at the state level
led to her inclusion in several working
committees formed to put together a
framework for federal legislative
proposals relating to genetic privacy
and nondiscrimination in health
insurance and employment. She coauthored a series of legislative
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recommendations relating to genetic
discrimination that were published in
the journal Science. These
recommendations formed the basis of
Rothenberg’s testimony at a number
of Congressional briefings and
hearings in 1996-97. In addition to
genetic privacy and discrimination
issues, Rothenberg has also testified
before Congress on the regulation of
the genetic testing market and human
cloning.
In addition to her legislative
work, Rothenberg has worked and
published extensively on the legal
and social implications of genetic
testing. Among others, she has
served on NIH’s Recombinant DNA
Advisory Committee; the Heredity
Susceptibility Gene Working Group
for the National Action Plan on
Breast Cancer; the Blue Ribbon
Panel on Genetic Technologies for
the National Conference of State
Legislators; and the Maryland Stem
Cell Commission.

HEALTH LAW SCHOLAR MARK ROTHSTEIN VISITING
AT UNIVERSITY OF MARYLAND SCHOOL OF LAW

M

ark Rothstein, a
prominent scholar in the
field of health law,
bioethics, and genetics, is visiting at
the School of Law this semester.
Professor Rothstein is teaching the
Genetics and the Law Seminar and a
first year torts class. When not in
Baltimore sharing his wealth of
knowledge with Maryland law
students, Rothstein is at the
University of Louisville where he
holds the Herbert F. Boehl Chair of
Law and Medicine and is Director of
the Institute for Bioethics, Health
Policy and Law at the University of
Louisville School of Medicine.
Fifteen second and third year law
students eagerly enrolled (and
several stayed on the waiting list) for
Professor Rothstein’s genetics
course, anxious to take the class
from a recognized national expert in
the field. In the seminar, students
explore the intersection between
law and genetics and the ethical,
legal, and social implications arising
from genetic technologies. Topics
touched on in the class include
genetic research, ownership of
genetic material, reproductive
genetics, clinical genetics, behavioral
genetics, DNA forensics, and genetic
privacy and confidentiality. The
course was first taught by Dean
Karen Rothenberg, then by Adjunct
Faculty member Gail Javitt, a policy
analyst at the Genetics and Public
Policy Center and a research scien-

tist at the Berman Bioethics Institute
of Johns Hopkins University.
Professor Rothstein is a leading
authority on the ethical, legal, and

Mark Rothstein
social implications of genetics,
privacy, occupational health,
employment law, and public health
law. He is Chair of the
Subcommittee on Privacy and
Confidentiality of the National
Committee on Vital and Health
Statistics, the statutory advisory
committee to the Secretary of Health
and Human Services on health
information policy, including the
privacy regulations of the Health
Insurance Portability and
Accountability Act. He is also a
member of the Board of Directors of
the American Society of Law,

Medicine and Ethics. He is the
author or editor of 19 books. His
latest book is GENETICS: ETHICS, LAW
AND POLICY (with Andrews &
Mehlman) (Thomson/West 2d ed.
2006). His current scholarship
includes work on the legal and
ethical issues in transgenerational
environmental epigenetics, the
allocation of scarce health care
resources in an influenza pandemic,
and privacy and confidentiality in
electronic health records and
networks.
Rothstein has many long-time
friends and colleagues at the
University of Maryland, including
Dean Rothenberg. According to
Rothstein, “spending a semester with
them and collaborating on research
should be very rewarding. Also,
being here will give me the
opportunity to spend time with my
daughter Lisa, a graduate of the
UMD School of Social Work, who
lives in Baltimore.” Rothstein’s
wife, Laura Rothstein, is former
Dean and Professor of Law at the
University of Louisville. His other
daughter, Julia, although a law school
graduate herself, is currently working
as an actress in Los Angeles.
In addition to teaching, Rothstein
will discuss his scholarship in the
area of genetics at a brown bag
lunch for students sponsored by the
Student Health Law Organization in
November.
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L&HCP PROGRAM FACULTY . . .
LAW & HEALTH CARE PROGRAM FACULTY STUDY
PUBLIC HEALTH LAW ACCESS AT THE LOCAL LEVEL

A

few years ago in my role as public
health officer, I was told there was
an outbreak of the noro virus in
one of the dorms at the local university that
was housing summer campers, and that
several campers had been sent to the local
Emergency Department because they had
been vomiting. We determined that
someone had left the camp (probably the
sentinel case) before we had a chance to act,
but the virus was rapidly spreading among
the remaining campers. We discussed the
possibility of quarantine with the County
attorney and the University attorney, but
discovered that none of us had a very good
understanding about what we could or could
not do with the campers. We requested
voluntary compliance, but the camp director
failed to comply. There were other consequences to be considered than just the ill
campers. Students would be returning to
the campus within the next 30 days and
because of the risk of contracting the virus,
the professional sports team that was to
come to the campus the following week,
cancelled. This was a significant economic
loss for the community. After it was really
too late, I learned that as the local health
officer I have significant authority to act in
this type of situation. I would have handled
it differently if I knew legally what I could
have done.
This vignette, which illustrates the
difficulty that local health officials
often have because they did not have
access to adequate legal advice,
comes from an interview Diane
Hoffmann, Director of the Law &
Health Care Program, and Virginia
Rowthorn, Managing Director of the
Program, conducted as part of their
research for a paper they were
commissioned to write on building
public health law capacity at the local
level. The paper is one of three
commissioned by the Public Health
Law Association (PHLA), which
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received grant funding from the
Robert Wood Johnson Foundation
to study the issue of how best to
increase knowledge and use of
public health law at the local health
department level. The genesis for
the paper is PHLA’s belief that:
The successes and failures of public
health practice are immediately
apparent in our towns, cities and
counties. On a daily basis, this is
where contagious diseases are
tracked, water is fluoridated, and
many other public health initiatives
are implemented. It is in these
localities, however, where public
health legal capabilities are the
weakest. All too often, there is
minimal legal support provided to
local health officials. Public health
staff may work for years having little
or no access to an attorney . . .
Where access to legal services does
exist, counsel is rarely conversant
with public health capabilities or the
relevant public health case law.
PHLA is an association of scholars,
practitioners, and attorneys working
in the area of public health. The
organization was established to
promote 1) the view that law is
fundamental to the origin, understanding and delivery of public health
services and 2) the concept that law
improves the likelihood that residents
of local, state, national, tribal, and
international communities can lead
healthy, long, and productive lives.
PHLA staff and committees publish
educational materials and work
collaboratively with other organizations on conferences and teleconferences. Two of PHLA’s present
leaders, Marty Wasserman, MD, JD
(President of PHLA and Executive
Director of MedChi, the Maryland
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State Medical Society) and Dan
O’Brien, JD (Immediate Past President of PHLA and Principal Counsel,
Maryland Department of Health and
Mental Hygiene) are School of Law
alumni.
Hoffmann and Rowthorn interviewed local health officials and
municipal attorneys across the country,
as well as officials in state and national
organizations that represent the
interests of these local players such as
the National Association of County &
City Health Officials (NACCHO), the
Association of State and Territorial
Health Officials (ASTHO), and the
International Municipal Lawyers
Association (IMLA). The interviews,
along with research on public health
law infrastructure at the local level,
informed their critique of possible
models for increasing the public
health law capacity at local health
departments, as well as mechanisms
for delivery of legal information and
advice to local health officers and their
attorneys. Based on their analysis,
Hoffmann and Rowthorn recommended a mechanism for delivery of
public health legal services that
combines state-based academic legal
resources centers and a national
organization to coordinate the work of
the state centers.
Hoffmann and Rowthorn, along
with the authors of the other two
commissioned papers, Jason Smith
(Associate Executive Director of the
Public Health Advocacy Institute at
Northeastern School of Law) and
Ross Silverman (Associate Professor
at Southern Illinois School of Medicine), will present the results of their
study at a November Summit organized by PHLA during the American
Public Health Association Meetings
in Washington, D.C.

PROFESSOR TOM PÉREZ APPOINTED MARYLAND
SECRETARY OF LABOR, LICENSING, AND REGULATION

O

n March 15, 2007, former
Law & Health Care
Program faculty member
Tom Pérez was chosen by Maryland’s
Governor Martin O’Malley to serve as
Secretary of Labor, Licensing, and
Regulation. Pérez was an Associate
Professor at the law school and served
as Director of the Clinical Law Program from 2001 to 2003. Prior to
joining the law school, Secretary Pérez
was Director of the Office of Civil
Rights at the U.S. Department of
Health and Human Services.
Despite his new duties, Pérez is
still involved in a number of health
care-related advocacy projects and
will continue to teach as an adjunct in
the Law & Health Care Program.
Most recently, Pérez co-authored a
study commissioned by the W.K.
Kellogg Foundation entitled, “Health
Professions Accreditation and Diversity: A Review of Current Standards
and Processes.” The study, released
this year, sought to capture the
connection between accreditation
and a culturally and ethnically diverse
workforce. The report provides
observations on the existing accreditation process and recommendations
for how to produce a health care
workforce that is racially and ethnically diverse and culturally competent. The report calls accreditation,
“a potentially important catalyst for
change whose full potential has yet to
be realized.” Two former Law &
Health Care Program students,
Deepti Kulkarni and Brooke
Courtney, helped Pérez and the
other authors with research for the
report.
The Kellogg Foundation study was
the latest in a series of reports and
articles Pérez has authored on health
disparities. In 2002, Pérez was
commissioned to author a paper that

was part of the Institute of Medicine’s
landmark Unequal Treatment report. He
used this research to effect changes at
the national level as a member of the
Sullivan Commission on Diversity in
the Healthcare Workforce. In September of 2004, the Commission
released a report entitled, “Missing
Persons: Minorities in the Health
Professions,” that includes numerous
recommendations as to how to increase the number of minorities in the
health care workforce.
Pérez is also a member of the Kaiser
Commission on Medicaid and the
Uninsured and chair of a national
selection committee for the Robert

IN REMEMBRANCE

Wood
Johnson
Foundation
that will
review
proposals from
across
the
country
Tom Pérez
to fund
roughly a dozen projects designed
to expand the capacity of non-profit
organizations to advocate for long
term solutions to issues of access to
healthcare for vulnerable people.

OF JOAN

O’SULLIVAN

of community and professional
n May, the Law & Health
education programs, promoted
Care Program lost one of
collaborations with the local bar,
its former outstanding faculty
and served as mentor
members. Joan
to less experienced
O’Sullivan passed away
legal services
on May 19, 2007. She
advocates around the
died at home with her
state. In addition,
family after an extended
Professor O’ Sullivan
illness. Joan came to the
co-founded the Anne
law school in 1993
Arundel County,
where she developed,
Maryland
and then taught, clinical
Representative Payee
courses on elder law and
Project, an alternative
health law. She was very
to guardianship for
popular with her stuindividuals unable to
dents and devoted to the
manage their Social
elderly clients served by
Security or other
the clinic.
Joan O'Sullivan
government benefits
Prior to coming to the
and was a founding
law school, Joan worked for the
member
of
the
Maryland State Bar
Maryland Legal Aid Bureau’s Senior
Association Elder Law Section.
Citizens Law Project in Annapolis as
Joan authored a number of books,
managing attorney from 1977 to 1993.
including THE MARYLAND
She represented thousands of lowGUARDIANSHIP BENCH BOOK; NURSING
income seniors, conducted hundreds

I

Cont. on page 12
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In Remembrance of Joan O'Sullivan
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HOMES: WHAT YOU NEED TO KNOW;
ASSISTED LIVING IN MARYLAND: WHAT
YOU NEED TO KNOW; and THE
GUARDIANSHIP HANDBOOK: A GUIDE
TO ADULT GUARDIANSHIP AND
GUARDIANSHIP ALTERNATIVES IN
MARYLAND.
Over the course of her career,
Joan was recognized by her peers
for her outstanding contributions to
elder rights advocacy. She was the
recipient of the Maryland Legal
Services Corporation Distinguished
Service Award, the Maryland Bar
Foundation Award for Legal

Excellence and, in 2004, the
National Aging and Law Award.
Her colleagues at the Law School
described Joan as an outstanding
teacher who inspired her students
through her own work. She was
skilled at guiding her students as
they struggled to understand the law
and represent clients in the Elder
Law Clinic. She guided them with a
light touch, displaying understanding and compassion. She recognized when students lacked confidence in their abilities and bolstered
their confidence when they needed

it. She also helped them learn and
grow from their mistakes. Because
of their experience in the Elder Law
Clinic, a number of her students
went on to practice elder law after
they graduated from law school in
law firms and in advocacy organizations.
Joan will be remembered for her
tireless work aimed at preserving
individual rights of the elderly, and
missed as a friend to many at the law
school and in the elder law
community.

L&HCP STUDENTS . . .
FOCUS
OF

ON

EXTERNSHIPS . . . UNIVERSITY OF MARYLAND SCHOOL

LAW STUDENT AT THE ABA COMMISSION ON LAW AND AGING

U

niversity of Maryland
School of Law student
Monica Sethi was chosen
by the ABA Commission on Law
and Aging to serve as its 2007
Borchard Foundation Center on Law
and Aging Intern. This prestigious
summer position in Washington,
D.C. proved to be a wonderful
experience for Monica, a rising thirdyear student who is pursuing the
health law certificate. Monica
worked closely with ABA Commission Director Charlie Sabatino to
review surrogate decision-making
and advance health care directive
statutes in all 50 states. In addition,
Monica synthesized all 50 states’ legal
positions on medical futility as the
basis for writing an article comparing
each state’s stance on medically futile
health care. Her findings will be
published in an article entitled
“Patient’s Right to Direct Own
Health Care vs. Physician’s Right to
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Monica Sethi
Decline to Provide Treatment,”
which will appear in a forthcoming
issue of Bifocal, the Commission’s
newsletter.
Of her internship, Monica
commented, “[a]n attractive part of
working at the Commission is that
everyone in the office is an expert in
his or her field and is always willing
to take time out to talk to interns
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about law school, careers, and
anything else. The attorneys value
their interns and give substantive
assignments that are both challenging and interesting. The most
exciting part of the internship was
keeping abreast of important issues
in elder law by attending numerous
Congressional hearings and briefings in both the House and Senate.
Working with the ABA Commission was a great opportunity that I
recommend to other students
interested in health policy and elder
law.”
In addition to pursuing the health
law certificate, Monica is an associate
editor for the school’s Journal of Health
Care Law & Policy and is a contributing
writer of health articles for the law
school’s newspaper, The Raven. She
also served as a law clerk after her first
year in law school in the in-house
counsel’s office at Maxim Healthcare
Services in Columbia, Maryland.

MD/PHD STUDENT WINS APHA AWARD
FOR LAW SCHOOL SEMINAR PAPER

I

n Spring 2006, Shayna Rich, a
University of Maryland School
of Medicine MD/PhD candidate,
enrolled in a new seminar offered at
the law school entitled “Legal and
Policy Issues in End-of-Life Care.”
Students in this multidisciplinary
seminar, taught by Law & Health
Care Program Director Diane
Hoffmann, and Assistant Attorney
General Jack Schwartz, examined
the last three decades of legal
developments in the law governing
decision making about the use of
life-sustaining medical treatments.
The course encompassed the leading
cases from Quinlan through Schiavo
and focused on challenges that
continue to confront patients,
families, health care providers and
policy makers in improving end-oflife care. Students were required to
write a research paper evaluating
current legal and policy frameworks

for decision making and medical
treatment at the end-of-life.
Shayna decided to take the
course because of her interest in
hospice and end-of-life care issues
and because she had taken another
interdisciplinary course at the
School of Law – Critical Issues in
Health Care with Professor
Hoffmann. In the end-of-life
course, Shayna conducted research
and wrote about eligibility requirements for hospice under the Medicare program. She submitted her
paper to the American Public
Health Association’s (APHA)
Gerontological Health Section’s
annual manuscript competition. In
August, she learned that her paper,
“Policy Issues Related to the SixMonth Prognostic Standard for
Eligibility in the Medicare Hospice
Benefit,” was awarded Honorable
Mention for the 2007 Laurence G.

Branch Doctoral Student Research
Award. The Gerontological Health
Section (GHS) of APHA was created
to stimulate public health activities
to improve the health, functioning,
and quality of life of older persons
and to call attention to their health
care needs. In pursuing this mission, the GHS makes a number of
awards to scholars in the area of
gerontology, particularly for research
and advocacy aimed at reforming
governmental health care programs
such as Medicare and Medicaid.
Shayna will present her paper at the
American Public Health Association
annual meeting on November 6.
After graduation from both
programs, Shayna is planning to
pursue a combined clinical and
research career with a focus on
issues related to hospice and palliative care.

2007 HEALTH LAW CERTIFICATE AWARDEES

A

t a breakfast reception held
on May 16, 2007 at the
School of Law, Professor
Diane Hoffmann, Director of the
Law & Health Care Program, and
Virginia Rowthorn, Managing
Director of the Program, awarded
the Health Law Certificate to 25
graduating students. This ceremony
marked the 10th year that the Law &
Health Care Program at the School
of Law has been awarding the
Health Law Certificate to those
students who have concentrated
their legal studies in the area of
health law. The certificate
awardees, in addition to all of the
requirements to graduate from law
school, also fulfilled the rigorous
requirements for the concentration

in health law, which include health
law seminars, an experiential
learning component, and a writing
requirement. Many of these
students went far beyond the
minimum requirements to earn the
certificate. Many completed more
than one health law externship and
virtually all of them took part in
non-curricular health law activities
such as participating in Health Law
Moot Court, working on the Journal
of Health Care Law & Policy, and
participating in the Student Health
Law Organization.
The certificate recipients this year
are representative of the law
school’s wonderfully diverse
student body. Some of them are
older students and have families

and children. Others have had
extensive work experience, coming
to law school from prior careers in
health care such as nursing or health
policy. Some have accepted positions in the federal government,
others in health law practices in
prominent private law firms, others
will work in health-related nonprofit organizations. Each of the
certificate awardees are special in
their own way and all of them will
be invaluable ambassadors for the
Program as they start their legal
careers. Below, we focus on five
certificate students whose various
backgrounds and career aspirations
highlight the breadth of health law
and its (future) practitioners.
Cont. on page 14
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2007 Health Law Certificate Awardees
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Rachel Grunberger

Joanne Hawana

Rachel came to the law school
from the University of Maryland,
College Park with a B.A. in Psychology and English. After her first
year of law school, Rachel was a
summer associate at Gallagher,
Evelius & Jones in Baltimore and
after her second year, was a summer
associate at Covington & Burling in
Washington, D.C. She won the
Best Journal Petition Award in 2005,
earned a spot on the Maryland Law
Review, and, in her third year, served
as its Executive Notes and Comments Editor. In addition, Rachel
was a Legal Writing Program Fellow
during her second year. Her written
work has been published twice. The
first piece, entitled, “Johnson v.
California: Setting a Constitutional
Trap for Prison Officials,” appeared
in the Maryland Law Review and the
other, “Civil Legal Needs of Individuals in Drug Treatment,” which
she co-authored, appeared in the
Journal of Substance Abuse Treatment.
Rachel took a number of health
law courses. Adjunct Professor Lisa
Ohrin, who taught Rachel in her
Long Term Care Seminar, called
Rachel “one of those students who,
although you do not have enough
time to get to know them very well,
you hope that you cross paths later
as colleagues. She is bright, energetic, and simply a delightful person.
A big part of lawyering is connecting
to your clients, and Rachel will
score high marks in that department.”
Rachel is the envy of the other
health law certificate students. Not
for her law school accomplishments
— which are many — but because
her first position out of law school
will be a clerkship with Judge Alan
Kay of the U.S. District Court for
the District of Hawaii in Honolulu.

Joanne brought a wealth of
experience to her law school career.
After graduating with a B.S. in
Biology from the College of William
& Mary and an M.S. in Molecular
Genetics & Microbiology from the
University of Medicine & Dentistry
of New Jersey, Joanne was a science
policy and research reporter for The
Blue Sheet: Health Policy and Biomedical
Research, a weekly publication for the
biomedical research community. As
part of her “beat,” she covered
science agencies, private research
groups, and Capitol Hill. Joanne
arrived at the law school in 2004 as a
Leadership Scholar and has translated
her background in science into twin
pursuits at the law school –
intellectual property law and health
law.
In terms of intellectual property
law, Joanne served as Co-President
of the Maryland Intellectual Property Student Association, as a student
attorney in the Intellectual Property
Law Clinic, and as a Fellow at the
Office of Biotechnology Activities at
the National Institutes of Health.
In terms of health law, Joanne
served as treasurer of the Student
Health Law Organization and
Manuscripts Editor for the Journal of
Health Care Law and Policy. She was
instrumental in soliciting and
choosing the well-regarded articles
that comprise the 10th anniversary
issue of the Journal.
Joanne externed in Washington,
D.C. at BIO, the national biotech
trade organization, where she had an
opportunity to work on the biotech
issues that she’s written about as a
journalist and studied at the law
school. She also served as a Research Assistant for both Professors
Diane Hoffmann and Michael
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Greenberger, Director of the Center
for Health and Homeland Security
at the law school. This fall, Joanne
will begin work as an associate at
Arent Fox in Washington D.C. in
their Life Sciences practice.

Dawn Rock
Dawn earned the health law
certificate as an evening student while
juggling a family and a full-time job as
the Director of Corporate Compliance
at the Johns Hopkins Health Care
Corporation. In her position (which
she still holds), she drafts compliance
plans and codes of ethics, investigates
allegations of fraud and abuse, and
monitors compliance with HIPAA
regulations. Before her time at
Hopkins, Dawn worked for the Kaiser
Foundation Health Plan of the MidAtlantic States as Clinical Compliance
Coordinator and, before her life in the
world of health care compliance,
Dawn worked as a paralegal for
several years. She graduated from the
University of Maryland Baltimore
County in May 2000.
Despite her impressive schedule,
Dawn managed to complete an
externship during law school by
cobbling together vacation and leave
time. In the summer of 2006, Dawn
clerked in the Office of the Maryland Attorney General’s Medicaid
Fraud and Abuse Division. Her
supervisor, Rich Bardos, was
delighted to have an intern with
health care experience on hand. He
commented that Dawn “brought a
caring and intelligent real-life
perspective to our practice. Dawn
used her experience in fraud detection to be creative in solving the
confusion that arises from the maze
of regulations that surround the
Medicaid program. And she is just
plain fun to work with.”

Professor Jaime Doherty, who was
Dawn’s professor for Legal Issues in
Managed Care, said “Dawn was a
challenging student because she
came to my class with a much more
sophisticated understanding of legal
issues in managed care than many of
the other seminar students, due to
her experience as a paralegal at
Kaiser Permanente. It was very hard
for me to get away with making
broad professorial generalizations!
Boy I hate that.”
While Dawn decides what her
next step will be, she will continue
her work at Johns Hopkins for the
near future.

Marc Snyder
Marc arrived at the law school
having graduated summa cum laude
from Clark University in Worcester,
Massachusetts where he majored in
Computer Science. For two years in
a row, he was given the Outstanding
Academic Achievement in Computer
Science Award and received high
honors on his paper, “The Pebble
Algorithm and Other Topics in
Bioinformatics.” He also worked as
a research assistant in both a biology
and biochemistry lab and his
publications include a work entitled “Automated Phylogenetic
Taxonomy: An Example in the
Homobasidiomycetes” which
appeared in Systematic Biology.
Marc dove into health law from
the minute he had the opportunity

to take an elective at the law school.
He took the Insurance Law Seminar;
Health Care Law & Policy;
Children’s Health, Violence and the
Law; and the Civil Rights of Persons with Disabilities Clinic with
Professor Charmatz. Professor
Charmatz commented that he
enjoyed working with Marc because
he worked tirelessly on behalf of his
clinic clients, including a difficult
case in which a child was refused
medical treatment because of his
parents’ disability.
Marc was a summer associate after
his second year in law school at the
law firm of Fried, Frank in Washington, D.C. and is beginning his
career there as an associate this fall.

Arianne Spaccarelli
Arianne was another of the law
school’s stellar evening students.
While attending school, Arianne
worked as an Administrator and
Policy Analyst at the Office of
Youth Violence Prevention in
Baltimore where she managed grant
development for programs with a
combined annual budget of over $2
million. Before that, she was a
KidStat Coordinator for the Mayor
of Baltimore’s Office of Children,
Youth and Families where she
developed strategies to enhance
program compliance for juvenile
offenders served by the program.
Arianne graduated in 2000 from
Harvard University with a cum laude

degree in Modern European History
and while there, earned the Robert
C. Byrd Scholarship four years in a
row for academic and extracurricular
achievement.
Arianne took the Tobacco Control Seminar with Professor Kathleen
Dachille who called Arianne “an
articulate and bright young professional. Her contributions demonstrated critical thinking and earnest
internal analysis. Similarly,
Arianne’s seminar paper was excellent; her analysis and research were
far above the norm.” Diane
Hoffmann, who got to know
Arianne in the Spring of 2005 in her
Critical Issues in Health Care class,
noted that “Arianne stood out as one
of the brightest students in the class.
Her comments were always on
point.”
In her final semester of law
school, Arianne interned for Dan
O’Brien, the Chief Attorney of the
Maryland Department of Health and
Mental Hygiene, where she performed legal research and assisted in
litigation preparation for Medical
Assistance hearings and enforcement
actions by professional boards.
O’Brien called her “one of the best
[interns] we’ve seen. We’re certain
she will have a great career.” In the
summer of 2005, she was a teaching
assistant for Professor Michael
Greenberger, Director of the Center
for Health and Homeland Security,
where she is now working as a
Fellow.
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LAW SCHOOL TO THE EXECUTIVE BRANCH . . .

he Law & Health Care
Program will be well
represented in Washington
D.C. this year as three 2007 Health
Law Certificate awardees begin
their careers as Presidential
Management Fellows. Aparna
Sriram, Fran Huber and Brian
Kehoe begin their two-year
Fellowships this fall.
The Presidential Management
Fellowship (PMF) is a leadership
development program designed to
attract outstanding men and women
from a variety of academic disciplines
to federal government service.
Candidates must express a clear
interest in, and commitment to,
excellence in the leadership and
management of public policies and
programs. The two-year paid
Fellowship includes 80-hours of
formal classroom training each year,
challenging work assignments,
accelerated promotions,
developmental learning, and
networking opportunities. Fellows
apply to, and are hired directly by,
federal agencies. During the
Fellowship, students can remain in a
single department or rotate
throughout other federal agencies or
affiliates of the government, such as
the U.S. Congress or national
organizations such as the National
Governor’s Association.
Fran Huber, who was an evening
law student, served as Director of
Academic Affairs and PostProfessional Programs at the
Department of Physical Therapy and
Rehabilitation Science at the
University of Maryland School of
Medicine while studying law. Prior
to entering academia, Huber worked
as a licensed Physical Therapist for
several years in New Jersey,
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Pennsylvania, and West Virginia.
Her research in the area of physical
therapy has been published in several
peer-reviewed publications including
the American Journal of Sports Medicine
and Orthopedic Clinics of North
America. During her time at the law
school, Huber was a member of the
Moot Court Executive Board and the
winner of the “Best All Around”
award in the Fall 2004 Moot Court
Competition. She also externed
during her last semester of law school
for the U.S. Senate Committee on
Health, Education, Labor and
Pensions as part of Senator Barbara
Mikulski’s staff.
Huber dreamed of working in a
government agency after law school
because of her long-standing interest
in health policy. She applied to,
and was accepted as a Fellow in the
Office of Medical Policy within the
Social Security Administration
(SSA). She commented that “[t]his
is a great opportunity to get physical
therapists more involved in making
determinations about disability, a
particularly strong interest within my
profession.” She was also drawn to
the work culture at SSA. “They
work hard
and do very
important
work, but
still encourage their
employees
to have
balance in
their lives
— very
important
for me after
four years
Aparna Sriram
of full-time
work and evening school!”
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Brian
Kehoe, who
graduated
from the
University of
Rochester
(New York)
with a
degree in
Microbiology in 2002,
has had a
Brian Kehoe
long-time
interest in health law and biomedical research. During college,
he worked as a student intern in
two University of Rochester
laboratories and before law school,
worked for AstraZeneca and
Millennium Pharmaceuticals.
Brian came to the law school as a
Leadership Scholar and during his
time here, externed in the FDA
Office of Legislation (an experience that was profiled in the
Spring 2007 newsletter). When he
learned that he had been chosen as
a Fellow, he applied to work in
the same office. His supervisor
told the School of Law that she is
delighted to have him back for at
least part of his two-year Fellowship – and maybe permanently.
Fellows are guaranteed a position
in the federal government when
their Fellowship is completed.
Aparna Sriram graduated from
Northwestern University in
Evanston, Illinois with a B.S. in
Communications. Prior to law
school, she worked as a certified
mediator at the Harford County
Community Mediation Program
facilitating resolution of tort and
contract disputes. During law
school, she completed three
Cont. on page 20
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PHOTOS FROM THE 2007 HEALTH LAW CERTIFICATE AWARD BREAKFAST

(l-r) L&HCP Director Diane Hoffmann,
Rachel Grunberger, Professor Kathleen Dachille,
Melissa Sviatko

(l-r) Jennifer Martin, Joanne Hawana,
Marc Snyder

(l-r) Dawn Rock, Dean Karen Rothenberg,
Dawn's son Justin Jennings

(l-r) Arianne Spaccarelli,
Fran Huber
(l-r) Meaghan Shepard, Erika
Mellick, Deborah Herman
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LAW SCHOOL’S JOURNAL OF HEALTH
CARE LAW & POLICY ELECTS
NEW EDITOR-IN-CHIEF

T

he University of Maryland
School of Law’s Journal of
Health Care Law & Policy has
chosen Deepti Kulkarni, a rising
third year health law student, to
serve as its new Editor-in-Chief for
2007-08. Deepti brings a strong
academic background and a deep
interest in health law and policy to
her new position.
Deepti came to the law
school from the University of Maryland College
Park with a B.S. in
Business Marketing and
General Business. She
is pursuing the health
law certificate and has
already completed two
health law-related
internships – one at the
Public Justice Center in
Baltimore where she
researched issues relatDeepti
ing to health care,
privacy laws, and federal
Head Start regulations and the other
at the Center for Medicare &
Medicaid Services (CMS) where she
reviewed and responded to public
comments regarding proposed
amendments to physician selfreferral regulations. Last Spring,
Deepti served as a research assistant
for former Professor Thomas Pérez
(now Secretary of Labor, Licensing
and Regulation for the State of
Maryland. See story on page 11)
whom she assisted in completing a
report for the Kellogg Foundation
regarding workforce diversity in the
field of health care. This fall, Deepti
will intern for Judge Andre Davis of
the U.S. District Court for the
District of Maryland.
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In addition to her role on the
Journal, this year Deepti is also the
Volunteer Chair of the Student
Health Law Organization, Director
of the University of Maryland
Domestic Violence Hotline Project,
and Outreach Coordinator for the
Students Supporting the Women’s
Law Center
group. For her
outstanding
academic and
charitable pursuits
at the law school,
she has received
many awards
including the
Albert Schweitzer
Fellowship for
2007-08, a scholarship from the
Women’s Bar
Association of
Montgomery
Kulkarni
County for 200708, and the
University of Maryland School of
Law Dean’s Award for 2007-08.
On her new position, Deepti
commented that the Journal board,
“hopes to continue the Journal’s
charge of providing a forum for the
discussion of current and interesting
issues in health law, policy, and
bioethics.” The next issue (11:1)
will focus on articles stemming from
presentations made at a recent
symposium co-hosted by the School
of Law’s Center for Tobacco Regulation, Litigation & Advocacy and
the Law & Health Care Program.
The symposium, entitled “‘Safer’
Tobacco Products: Reducing Harm or
Giving False Hope?,” featured discussions regarding the history of
tobacco product development and
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regulation, the science behind risk
reduction products, smokeless
tobacco as a viable reduced harm
product, legal issues raised by the
cigarette manufacturers’ expansion
into the smokeless tobacco market,
regulatory policy for reduced harm
tobacco, and the impact of the
marketing of reduced risk tobacco
products. Currently, the Journal is
making plans for issue 11:2 and is
soliciting articles on a variety of
health law topics that illustrate both
the wide range of issues in the field
of health law and the diverse topics
addressed in the Journal.

Second Generation Genetics
Cont. from p. 3

dangerousness” based on evidence
of genetic conditions that predispose
individuals to violence.15
Our empirical research indicated
that judges weigh multiple factors
simultaneously when asked to admit
or compel a genetic test. Conceptually, they seem to apply a framework
that initially distinguishes between a
criminal or civil setting. In each of
those contexts they considered a
number of issues. We used our
survey results to construct a decision
matrix that might be used by judges
to evaluate these complex cases. The
decision matrix contemplates three
sets of questions placed along three
axes: 1) judicial questions (whether
the court is being asked to admit or
compel a test); 2) questions regarding
the purpose of the genetic informa-

tion (i.e., culpability, causation, or
consequence); and 3) genetic factor
questions (e.g., the scientific value of
the test; the nature of the genetic
trait/condition for which an individual is being tested; psycho-social
issues; genetic determinism; and
acceptance of the test).
The survey results and comments
of the judges also illuminated for us
a number of doctrinal and policy
tensions that surface in existing
criminal, evidence, constitutional,
and tort law when these second
generation tests are used (or efforts
are made to use them) in judicial
proceedings. One area in which this
is particularly apparent is in the
context of proving causation in tort
litigation. For example, in toxic tort
cases, plaintiffs, as an initial matter,
need to show that the toxic exposure
was “more likely than not” the
cause of the plaintiff’s disease or
condition. A genetic test might be
requested by the defendant to show
that the plaintiff had a genetic
susceptibility to the toxic substance.
While most courts in such a case
would adopt the well known tort
doctrine that one takes his victim as
one finds him – some courts have
accepted a defendant’s argument in
products liability cases that its
product was not “defective or
unreasonably dangerous” if the
plaintiff had a rare, idiosyncratic, and
unforeseeable reaction to the
product. The question of whether
this latter doctrine will apply to cases
where a product harms an individual
with a genetic susceptibility has yet
to be resolved. However, it raises
the question as to where, in these
cases, the burden should fall – on
the innocent victim or the product
manufacturer.

In addition to the challenges that
these genetic tests will bring to the
court room, we believe that their
widespread use in the courts may
have broader societal implications
and argue that it is critically important that judges, legislators and
policymakers look beyond the use
of genetic tests in individual cases to
the broader public policy implications of using such tests routinely in
court. Such implications may
include reluctance of individuals to
obtain genetic tests in a clinical
setting, even if they may be of
medical benefit or reluctance to
participate in genetic research.
In order to further explore the
implications of our findings for the
judiciary and society more broadly,
we are collaborating with the
National Human Genome Research
Institute to bring together a group of
20-25 judges, social scientists,
geneticists, and legal and other
academics with expertise in the
issues raised by genetic tests. The
purpose of the meeting is to provide
a forum for discussion of the types
of cases we included in our research
by a multidisciplinary group of
experts and exploration of the need
for modifications to evidentiary rules
or legal doctrines to accommodate
these new genetic tests.
Among others, participants in the
roundtable will include Dr. Francis
Collins of the NHGRI, Professor
Mark Rothstein, Director of the
Institute for Bioethics, Health Policy
and Law at the University of
Louisville School of Medicine (who
is visiting the law school this
semester), Professor Richard Boldt,
University of Maryland School of
Law, Professor Nita Farahany,
Vanderbilt University Law School,
Judge Barbara Rothstein, Director,

Federal Judicial Center, and Dr.
Mark Frankel, Director of the
Scientific Freedom, Responsibility
and Law Program at the American
Association for the Advancement of
Science.
— Diane Hoffmann, Professor of Law,
Director Law & Health Care Program
and Karen Rothenberg, Dean and
Marjorie Cook Professor of Law
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From the Law School to the Executive Branch
Cont. from p. 16

different externships. In the
Spring of 2006, she clerked for the
Honorable Lynne A. Battaglia, a
judge on the Court of Appeals of
Maryland. In her last semester in
law school, she did two
externships simultaneously – one
at the Education, Health and
Environment Committee of the
Maryland General Assembly and
one at the Centers for Medicare
and Medicaid Services in the
Office of the General Counsel.

Sriram chose the PMF program
because “it provided a wonderful
opportunity to dabble in law,
policy, and management with
various agencies and branches of
the federal government.” She was
attracted to federal government
service for the opportunity it
provides to do meaningful work on
behalf of others and because of the
family-friendly culture she encountered during the Fellowship interview process. Sriram interviewed
with several agencies, received
offers, and accepted her first-choice.

LAW & HEALTH CARE PROGRAM
UNIVERSITY OF MARYLAND SCHOOL OF LAW
500 WEST BALTIMORE STREET
BALTIMORE, MD 21201

Comments and letters should be
forwarded to the above address.
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Like Huber, she will be working at
the Social Security Administration in
Baltimore. Sriram will work on a
team that promulgates rules regarding disability determinations. She is
looking forward to the opportunity
to become a specialist in a body
system (such as neurology, mental
health, musculoskeletal, etc.) in
order to draft effective law-making
rules. Sriram is thrilled with having
been chosen as a Fellow. She
commented that, “the position
meets my professional expectations
in every way.”
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